As of 2025-09-18, the EV/EBITDA ratio of Pulmonx Corp (LUNG) is -0.46. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LUNG's latest enterprise value is 25.56 mil USD. LUNG's TTM EBITDA according to its financial statements is -55.44 mil USD. Dividing these 2 quantities gives us the above LUNG EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.2x - 13.8x | 13.7x |
| Forward P/E multiples | 9.6x - 14.1x | 10.3x |
| Fair Price | (12.98) - (17.88) | (15.40) |
| Upside | -937.5% - -1253.5% | -1093.7% |
| Date | EV/EBITDA |
| 2025-09-11 | -0.56 |
| 2025-09-10 | -0.51 |
| 2025-09-09 | -0.56 |
| 2025-09-08 | -0.57 |
| 2025-09-05 | -0.60 |
| 2025-09-04 | -0.60 |
| 2025-09-03 | -0.54 |
| 2025-09-02 | -0.59 |
| 2025-08-29 | -0.58 |
| 2025-08-28 | -0.62 |
| 2025-08-27 | -0.69 |
| 2025-08-26 | -0.62 |
| 2025-08-25 | -0.55 |
| 2025-08-22 | -0.56 |
| 2025-08-21 | -0.45 |
| 2025-08-20 | -0.43 |
| 2025-08-19 | -0.45 |
| 2025-08-18 | -0.50 |
| 2025-08-15 | -0.47 |
| 2025-08-14 | -0.43 |
| 2025-08-13 | -0.45 |
| 2025-08-12 | -0.49 |
| 2025-08-11 | -0.46 |
| 2025-08-08 | -0.46 |
| 2025-08-07 | -0.51 |
| 2025-08-06 | -0.51 |
| 2025-08-05 | -0.53 |
| 2025-08-04 | -0.53 |
| 2025-08-01 | -0.51 |
| 2025-07-31 | -0.67 |
| 2025-07-30 | -1.64 |
| 2025-07-29 | -1.59 |
| 2025-07-28 | -1.59 |
| 2025-07-25 | -1.78 |
| 2025-07-24 | -1.76 |
| 2025-07-23 | -2.10 |
| 2025-07-22 | -1.70 |
| 2025-07-21 | -1.66 |
| 2025-07-18 | -1.64 |
| 2025-07-17 | -1.59 |
| 2025-07-16 | -1.46 |
| 2025-07-15 | -1.31 |
| 2025-07-14 | -1.29 |
| 2025-07-11 | -1.45 |
| 2025-07-10 | -1.27 |
| 2025-07-09 | -1.33 |
| 2025-07-08 | -1.33 |
| 2025-07-07 | -1.26 |
| 2025-07-03 | -1.37 |
| 2025-07-02 | -1.32 |